Analyst Reco. AstraZeneca PLC Nasdaq Stockholm

Equities

Real-time Estimate Cboe Europe Other stock markets 07:47:26 2024-05-17 EDT			5-day change	1st Jan Change
1,652 ^SEK	+0.47%		-1.55%	+22.16%

05-16	AstraZeneca's Sipavibart Prevents COVID-19 in Immunocompromised Patients in Phase 3 Trial	MT
05-16	Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon...

ASTRAZENECA : UBS reiterates its Sell rating	05-15	ZD
ASTRAZENECA : Buy rating from JP Morgan	05-14	ZD
Jefferies Lifts AstraZeneca PT, Maintains Hold Rating	05-08	MT
ASTRAZENECA : Jefferies sticks Neutral	05-08	ZD
UBS raises Centrica to 'buy' from 'neutral	05-08	AN
Berenberg Raises AstraZeneca PT, Keeps Rating at Buy	05-07	MT
ASTRAZENECA : Berenberg keeps its Buy rating	05-07	ZD
AstraZeneca target raised; Antofagasta lowered	05-07	AN
ASTRAZENECA : Deutsche Bank gives a Neutral rating	04-30	ZD
ASTRAZENECA : JP Morgan maintains a Buy rating	04-29	ZD
Deutsche Bank likes Frasers; Barclays cuts JD	04-29	AN
ASTRAZENECA : DZ Bank sticks Neutral	04-26	ZD
ASTRAZENECA : UBS keeps a Sell rating	04-26	ZD
ASTRAZENECA : Deutsche Bank remains Neutral	04-26	ZD
ASTRAZENECA : Gets a Buy rating from Barclays	04-26	ZD
Barclays Raises AstraZeneca PT, Affirms at Overweight	04-26	MT
Peel Hunt cuts ConvaTec to 'reduce'	04-26	AN
ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade	04-25
ASTRAZENECA : UBS maintains a Sell rating	04-25	ZD
ASTRAZENECA : Jefferies sticks Neutral	04-25	ZD

No results for this search

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm